| Vaccines |
1 |
1 |
| Liver |
0 |
0.99 |
| Metabolic Syndrome |
0 |
0.65 |
| Aminotransferase |
0 |
0.56 |
| Hepatic Fibrosis |
0 |
0.56 |
| Immunoglobulin G (IgG) |
0 |
0.53 |
| Liver Disease |
0 |
0.95 |
| Fatty Liver |
0 |
0.5 |
| Biliary Disease |
0 |
0.49 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.49 |
| Liver Biopsy |
0 |
0.43 |
| Immunization |
0 |
0.6 |
| Transplantation |
0 |
0.85 |
| COVID-19 |
0 |
0.75 |
| Atrial Fibrillation |
0 |
0.18 |
| Food and Drug Administration (FDA) |
0 |
0.17 |
| Metabolism |
0 |
0.13 |
| Serology |
0 |
0.13 |
| Severe Acute Respiratory Syndrome (SARS) |
0 |
0.13 |
| Acute Respiratory Distress Syndrome |
0 |
0.11 |
| Rheumatoid Arthritis |
0 |
0.1 |
| Arthritis |
0 |
0.08 |
| Biopsy |
0 |
0.08 |
| Platelet Count |
0 |
0.07 |
| Blood |
0 |
0.04 |
| Cardiovascular disease |
0 |
0.04 |
| Cardiovascular Risk Management |
0 |
0.04 |
| Clinical Research |
0 |
0.04 |
| Cryoglobulinemia |
0 |
0.04 |
| Europe |
0 |
0.04 |
| Hemodialysis |
0 |
0.04 |
| Immunocompromise |
0 |
0.04 |
| Immunoglobulin A (IgA) |
0 |
0.04 |
| Lymphoma |
0 |
0.04 |
| Multiple Sclerosis |
0 |
0.04 |